Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Lee Baker currently holds 21,863 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Lee Baker has been a net seller of TPTX stock. They have purchased $50.4K and sold $6.7M worth of shares.
Brian Lee Baker's most recent insider trade was on Mar 23, 2021, when they sold 4,545 shares at $5.12 per share.
Brian Lee Baker serves as Executive at Turning Point Therapeutics, Inc. (TPTX). They have executed 24 insider transactions totaling $6.7M over their tenure at the company.
Brian Lee Baker holds the position of Executive at Turning Point Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Brian Lee Baker has shown a selling trading pattern, with $50.4K in total purchases and $6.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brian Lee Baker was on Jan 7, 2021, when they sold $2.7M worth of TPTX shares. This transaction involved 21,825 shares at $122.44 per share.
Brian Lee Baker currently owns 21,863 shares of Turning Point Therapeutics, Inc. (TPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Lee Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Lee Baker has 24 Form 4 filings on record as an insider at Turning Point Therapeutics, Inc..
Set alerts for Brian Lee Baker and 40,000+ other insiders.